{"cik":"0001678660","ticker":"PRLD","name":"Prelude Therapeutics Inc","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-12","last_filing_date":"2026-08-11","url":"/sec/cik-0001678660","insider_summary":{"total_transactions":17,"unique_insiders":11,"latest_transaction":"2026-06-09"},"recent_filings":[{"accession_number":"0001193125-26-387232","form_type":"8-K","form_type_family":"current","doc_date":"2026-09-10","title":"8-K — Prelude Therapeutics Inc — 2026-09-10","url_slug":"/sec/cik-0001678660/8-k/0001193125-26-387232","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001193125-26-387232-index.html"},{"accession_number":"0001193125-26-343469","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-11","title":"8-K — Prelude Therapeutics Inc — 2026-08-11","url_slug":"/sec/cik-0001678660/8-k/0001193125-26-343469","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001193125-26-343469-index.html"},{"accession_number":"0001193125-26-343475","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-11","title":"10-Q — Prelude Therapeutics Inc — 2026-08-11","url_slug":"/sec/cik-0001678660/10-q/0001193125-26-343475","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001193125-26-343475-index.html"},{"accession_number":"0001213900-26-076456","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-07-08","title":"SCHEDULE 13G — Prelude Therapeutics Inc — 2026-07-08","url_slug":"/sec/cik-0001678660/schedule-13g/0001213900-26-076456","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001213900-26-076456-index.html"},{"accession_number":"0001193125-26-265835","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-10","title":"8-K — Prelude Therapeutics Inc — 2026-06-10","url_slug":"/sec/cik-0001678660/8-k/0001193125-26-265835","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001193125-26-265835-index.html"},{"accession_number":"0001617541-26-000005","form_type":"4","form_type_family":"insider","doc_date":"2026-06-10","title":"4 — Dorton Katina — 2026-06-10","url_slug":"/sec/cik-0001617541/4/0001617541-26-000005","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001617541-26-000005-index.html"},{"accession_number":"0001193125-26-218162","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-12","title":"8-K — Prelude Therapeutics Inc — 2026-05-12","url_slug":"/sec/cik-0001678660/8-k/0001193125-26-218162","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001193125-26-218162-index.html"},{"accession_number":"0001193125-26-218173","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-12","title":"10-Q — Prelude Therapeutics Inc — 2026-05-12","url_slug":"/sec/cik-0001678660/10-q/0001193125-26-218173","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0001193125-26-218173-index.html"},{"accession_number":"0000929638-25-004602","form_type":"CORRESP","form_type_family":"other","doc_date":"2025-12-15","title":"CORRESP — Prelude Therapeutics Inc — 2025-12-15","url_slug":"/sec/cik-0001678660/corresp/0000929638-25-004602","edgar_url":"https://www.sec.gov/Archives/edgar/data/1678660/0000929638-25-004602-index.html"}],"related_endpoints":{"profile":"/sec/PRLD/profile","timeline":"/sec/PRLD/timeline","peers":"/sec/PRLD/peers","insider_pulse":"/sec/PRLD/insider-pulse","insider_summary":"/sec/PRLD/insider-summary","insider_transactions":"/sec/PRLD/insider-transactions","form144":"/sec/PRLD/form144","holdings_as_filer":"/sec/PRLD/holdings","financial_facts":"/sec/PRLD/financial-facts","derivatives":"/sec/PRLD/derivatives","officers":"/sec/PRLD/officers","insider_network":"/sec/PRLD/insider-network","risk_flags":"/sec/PRLD/risk-flags","filings":"/sec/PRLD/filings","cross_topic_dossier":"/api/v1/dossier?ticker=PRLD"}}